Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 565 results for "ranbaxy laboratories"

Ranbaxy settles Texas health care litigation
Business Standard India

Ranbaxy Laboratories : TO PAY $39.75 MILLION

Ranbaxy Laboratories will pay $39.75 million in tranches to the state of Texas in US to settle litigation related to its participation in the Texas Medicaid programme. The payments will be made till Aug 2015 . 4 Traders, 3 days ago
[x]  

16 images for ranbaxy laboratories

Sify, 6 days ago
Lawyer Herald, 1 week ago
Yahoo! News, 1 week ago
Reuters India, 1 week ago
Reuters UK, 1 week ago
Financial Express, 1 week ago
Business Today India, 1 week ago
GG2.net, 1 week ago
NRI Pulse, 1 week ago
Pharmaceutical Technology, 1 week ago
NDTV Profit

Merger with Sun Pharma: Ranbaxy moves HC for nod

Moving closer to finalising the biggest merger of two Indian medicine companies, Ranbaxy Laboratories has moved the Punjab and Haryana high court to get sanction for its scheme of amalgamation with Sun Pharmaceuticals. Taking up the petition of ...
 Hindustan Times5 days ago No CCI directive to sell business for merger nod with Sun Pharma: Ranbaxy  Economic Times1 week ago No CCI directive to sell biz for merger nod with Sun: Ranbaxy  Business Standard1 week ago 'No CCI directive to sell biz for merger nod with Sun'  Business Today India1 week ago
MedEsthetics Magazine

Ranbaxy launches ABSORICA in the US

Ranbaxy Laboratories has launched ABSORICA (isotretinoin) 25 mg and 35 mg capsules into the US healthcare market. ABSORICA has become the most prescribed branded oral isotretinoin in the US, as per a recent independent survey conducted with ...
 Express Pharma4 days ago Ranbaxy Laboratories : Launches ABSORICA┬« isotretinoin 25 mg and 35 mg Capsules in the U.S. Market  4 Traders2 weeks ago Ranbaxy Laboratories launches nodular acne drug in US  Individual.com2 weeks ago Ranbaxy launches acne treatment capsules in us  4 Traders2 weeks ago
[x]  

Competition Commission of India may okay Sun-Ranbaxy deal with rider

By Rajat Arora NEW DELHI: Sun Pharma and Ranbaxy Laboratories may have to give price and supply commitments, which include ensuring price caps on some drugs for a specific period, before the (CCI) gives its approval to their proposed merger. The ...
 Economic Times1 week ago Ranbaxy Laboratories : Competition Commission of India may okay Sun-Ranbaxy deal with rider  4 Traders5 days ago
[x]  
Rediff.com

Ranbaxy staff get pay-cut shield in Sun buyout

The agreement agreed to by Sun Pharmaceutical Industries for a buyout of Ranbaxy Laboratories from Daiichi Sankyo provides for a year's 'cooling period' during which the pay of Ranbaxy employees cannot be lowered, it is learnt. Ranbaxy is said to have also budgeted around Rs 65 crore for a retention bonus and identified 70-75 executives to distribute this. The year's cooling period is expected to start from the completion of the transaction between Sun and Daiichi, a source said. Ranbaxy ...
 Rediff.com6 days ago Ranbaxy Laboratories??? Staff Get Pay-Cut Shield In Sun Pharmaceutical Industries Ltd Buyout  BioSpace5 days ago

Ranbaxy Laboratories: Updates on termination of GDR programme

Ranbaxy Laboratories Ltd has informed BSE that the Company has notified the Bank of New York Mellon (hereinafter R anbaxy Laboratories Ltd has informed BSE that the Company has notified the Bank of New York Mellon (hereinafter "The Bank") to ...
 Moneycontrol.com1 week ago Ranbaxy Laboratories allots equity shares  Business Standard1 week ago Ranbaxy Laboratories' Q2 results on October 28, 2014  Money Control3 weeks ago Ranbaxy Laboratories: Outcome of court convened meeting of equity shareholders  Money Control1 month ago
Business Standard India

RANBAXY'S TOP EXECUTIVES IN THE US RESIGN

R (Indian Business Insight Via Acquire Media NewsEdge) Top executives of Ranbaxy Inc., the US subsidiary of Ranbaxy Laboratories of India, have left the company in the past two weeks. The executives who have left the company include country head ...
 TMC Net1 week ago Top Ranbaxy executives resign in US  Business Standard India1 week ago
[x]  

Ranbaxy Laboratories : US subsidiary sees 5 top-level exits including boss Venkat Krishnan

NEW DELHI : At least five senior executives of the US arm of Ranbaxy Laboratories , including its top boss Venkat Krishnan , have tendered their resignations or are planning to quit soon, people familiar with the matter said. Some of them are ...
 4 Traders1 week ago Ranbaxy's US subsidiary sees 5 top-level exits including boss Venkat Krishnan  Times of India1 week ago
Business Standard India

Sun, Ranbaxy may be asked to sell some businesses for CCI approval to merger

Sushmi Dey & Nivedita Mookerji | New Delhi October 15, 2014 Last Updated at 00:57 IST Ranbaxy Laboratories and Sun Pharmaceutical Industries are likely to be advised to sell parts of their businesses before the Competition Commission of India (CCI) ...
 Business Standard India1 week ago

Ranbaxy Lab gains on settling litigation concerning Texas Medicaid Program

Ranbaxy Laboratories is currently trading at Rs. 601.75, up by 3.70 points or 0.62% from its previous closing of Rs. 598.05 on the BSE. The scrip opened at Rs. 598.00 and has touched a high and low of Rs. 604.50 and Rs. 596.25 respectively. So far ...
 Arihant Capital1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy laboratories
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less